WallStreetZenWallStreetZen

NASDAQ: CGC
Canopy Growth Corp Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their CGC stock forecasts and price targets.

Forecast return on equity

Is CGC forecast to generate an efficient return?
Company
11.21%
Industry
0.07%
Market
17.32%
CGC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CGC forecast to generate an efficient return on assets?
Company
4.49%
Industry
0.04%
CGC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CGC revenue forecast

What is CGC's revenue in the next 2 years based on estimates from 4 analysts?
Avg 1 year Forecast
$226.1M-9.02%
Avg 2 year Forecast
$247.8M-0.31%
CGC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CGC revenue growth forecast

How is CGC forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
0.22%
Industry
8.48%
Market
9.65%
CGC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CGC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CGC vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
CGC$9.18N/AN/A
EOLS$12.51$22.60+80.66%Strong Buy
PAHC$18.55$13.00-29.92%Strong Sell
IRWD$5.95$16.33+174.50%Strong Buy
CRON$2.64$3.00+13.64%Hold

Canopy Growth Stock Forecast FAQ

What is CGC's revenue growth forecast for 2025-2026?

(NASDAQ: CGC) Canopy Growth's forecast annual revenue growth rate of 0.22% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.65%.

Canopy Growth's revenue in 2024 is $246,670,895.On average, 4 Wall Street analysts forecast CGC's revenue for 2025 to be $20,600,738,621, with the lowest CGC revenue forecast at $20,173,684,472, and the highest CGC revenue forecast at $20,951,803,190.

In 2026, CGC is forecast to generate $22,575,009,860 in revenue, with the lowest revenue forecast at $21,919,440,284 and the highest revenue forecast at $23,230,579,436.

If you're new to stock investing, here's how to buy Canopy Growth stock.

What is CGC's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: CGC) forecast ROA is 4.49%, which is higher than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.04%.

What is CGC's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: CGC) forecast ROE is 11.21%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.